DCOY
Decoy Therapeutics Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.88M
P/E Ratio
—
EPS
$-129.10
Beta
0.36
52W High
$239.40
52W Low
$5.37
50-Day MA
$7.37
200-Day MA
$37.71
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Decoy Therapeutics Inc.
Decoy Therapeutics Inc. focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that reduces the complexity of drug development and manufacturing. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-4.09M |
| Operating Margin | 0.00% |
| Return on Equity | -338.30% |
| Return on Assets | -36.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $11.07 |
| Price-to-Book | 0.49 |
| Price-to-Sales (TTM) | 15.86 |
| EV/Revenue | 72.64 |
| EV/EBITDA | 1.52 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 531,970 |
| Float | 528,440 |
| % Insiders | 0.58% |
| % Institutions | 12.42% |
Historical Volatility
HV 10-Day
66.83%
HV 20-Day
74.71%
HV 30-Day
68.30%
HV 60-Day
89.28%
HV Rank
—
Volatility is currently contracting
Data last updated: 4/23/2026